advanced ovarian cancer

GSK’s niraparib meets PFS goal in phase 3 PRIMA trial
Pharmaceutical Business Review
Tue, 10/1/19 - 09:56 am
GSK
clinicial trials
niraparib
Zejula
advanced ovarian cancer
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment
Pharmaforum
Wed, 08/14/19 - 11:01 am
AstraZeneca
Merck
Lynparza
clinical trials
advanced ovarian cancer
ovarian cancer
Calquence